Suppr超能文献

特发性静脉血栓栓塞患者中非酒精性脂肪肝的高患病率。

High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

机构信息

Department of Clinical and Experimental Medicine, Federico II University Medical School of Naples, Via S. Pansini, 5, 80131 Naples, Italy.

出版信息

World J Gastroenterol. 2010 Dec 28;16(48):6119-22. doi: 10.3748/wjg.v16.i48.6119.

Abstract

AIM

to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with idiopathic venous thromboembolism (VTE).

METHODS

in a case-control study, after excluding subjects with well-consolidated risk factors for VTE, idiopathic VTE was documented in 138 consecutive patients who were referred to our department. Two hundred and seventy-six healthy sex/age/body-mass-index-matched subjects, without any clinical/instrumental evidence of VTE, served as controls. All underwent a clinical/laboratory/ultrasound assessment for the presence of metabolic syndrome and NAFLD.

RESULTS

NAFLD was detected in 112/138 cases (81%) and in 84/276 controls (30%) [risk ratio: 2.7, 95% confidence interval (CI): 2.2-3.2, P < 0.0001]. Metabolic syndrome and smoking habit were more prevalent in patients with idiopathic VTE. The high prevalence of NAFLD in VTE was also confirmed after adjustment for inherited thrombophilia. NAFLD was clearly predicted by VTE (odds ratio: 1.8, 95% CI: 1.2-2.7, P < 0.0001).

CONCLUSION

NAFLD was independently associated with idiopathic VTE.

摘要

目的

评估特发性静脉血栓栓塞症(VTE)患者中非酒精性脂肪性肝病(NAFLD)的患病率。

方法

在一项病例对照研究中,排除 VTE 明确危险因素后,对我院收治的 138 例特发性 VTE 患者进行了病例记录。276 名性别/年龄/体重指数匹配、无任何临床/仪器 VTE 证据的健康受试者作为对照组。所有受试者均接受了代谢综合征和 NAFLD 的临床/实验室/超声评估。

结果

138 例患者中有 112 例(81%)和 276 例对照组中有 84 例(30%)检测到 NAFLD[风险比:2.7,95%置信区间(CI):2.2-3.2,P<0.0001]。特发性 VTE 患者中代谢综合征和吸烟习惯更为常见。在调整遗传性血栓形成倾向后,VTE 患者中 NAFLD 的高患病率仍然成立。NAFLD 可明确预测 VTE(比值比:1.8,95% CI:1.2-2.7,P<0.0001)。

结论

NAFLD 与特发性 VTE 独立相关。

相似文献

1
High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.
World J Gastroenterol. 2010 Dec 28;16(48):6119-22. doi: 10.3748/wjg.v16.i48.6119.
2
Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.
Clin Appl Thromb Hemost. 2017 Nov;23(8):1018-1027. doi: 10.1177/1076029616665925. Epub 2016 Aug 31.
3
The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population.
Metab Syndr Relat Disord. 2011 Jun;9(3):197-201. doi: 10.1089/met.2010.0117. Epub 2011 Feb 25.
4
Metabolic syndrome is associated with venous thromboembolism in the Korean population.
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):311-5. doi: 10.1161/ATVBAHA.109.184085.
5
Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease.
Arch Med Res. 2014 Jan;45(1):52-7. doi: 10.1016/j.arcmed.2013.12.003. Epub 2013 Dec 12.

引用本文的文献

2
Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitis.
J Thromb Haemost. 2024 Dec;22(12):3572-3580. doi: 10.1016/j.jtha.2024.08.023. Epub 2024 Sep 19.
3
A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes.
Hepatology. 2025 Jul 1;82(1):165-183. doi: 10.1097/HEP.0000000000001066. Epub 2024 Aug 27.
4
The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study.
Res Pract Thromb Haemost. 2024 May 20;8(4):102447. doi: 10.1016/j.rpth.2024.102447. eCollection 2024 May.
5
A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes.
medRxiv. 2024 Feb 4:2024.02.03.24302258. doi: 10.1101/2024.02.03.24302258.
8
Sex-specific aspects of venous thromboembolism: What is new and what is next?
Res Pract Thromb Haemost. 2022 May 23;6(4):e12722. doi: 10.1002/rth2.12722. eCollection 2022 May.
9
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences.
Biomedicines. 2022 Jan 24;10(2):249. doi: 10.3390/biomedicines10020249.

本文引用的文献

1
Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.
Atherosclerosis. 2010 Apr;209(2):585-91. doi: 10.1016/j.atherosclerosis.2009.10.011. Epub 2009 Oct 13.
2
Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1.
J Hepatol. 2009 Sep;51(3):535-47. doi: 10.1016/j.jhep.2009.03.026. Epub 2009 May 18.
3
Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy.
Intern Emerg Med. 2009 Aug;4(4):315-23. doi: 10.1007/s11739-009-0240-9. Epub 2009 Apr 7.
4
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Eur J Gastroenterol Hepatol. 2009 May;21(5):504-11. doi: 10.1097/MEG.0b013e3283229b40.
5
Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.
AJR Am J Roentgenol. 2009 Apr;192(4):909-14. doi: 10.2214/AJR.07.4016.
7
Metabolic syndrome, haemostasis and thrombosis.
Thromb Haemost. 2008 Jun;99(6):995-1000. doi: 10.1160/TH07-11-0682.
9
Venous thromboembolism in association with features of the metabolic syndrome.
QJM. 2007 Nov;100(11):679-84. doi: 10.1093/qjmed/hcm083. Epub 2007 Sep 10.
10
Venous thromboembolism--a manifestation of the metabolic syndrome.
Haematologica. 2007 Mar;92(3):374-80. doi: 10.3324/haematol.10828.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验